US 4667016A
· Lai et al.
· 1987
[cited by applicant]
US 4703008A
· Lin
· 1987
[cited by applicant]
US 5459031A
· Blumen et al.
· 1995
[cited by applicant]
US 5808006A
· Builder et al.
· 1998
[cited by applicant]
US 6399333B1
· Burg et al.
· 2002
[cited by applicant]
US 6506598B1
· Andersen et al.
· 2003
[cited by applicant]
US 7972810B2
· Crowell et al.
· 2011
[cited by applicant]
US 20080102492A1
· Egrie et al.
· 2008
[cited by applicant]
US 20160222075A1
· Crowell et al.
· 2016
[cited by applicant]
EP 0148605A2
· 1985
[cited by applicant]
EP 0428267A2
· 1991
[cited by applicant]
EP 0513738A2
· 1992
[cited by applicant]
EP 1085083A1
· 2001
[cited by applicant]
EP 1298217A1
· 2003
[cited by applicant]
EP 1394179A1
· 2004
[cited by applicant]
WO WO8502610A1
· 1985
[cited by applicant]
WO WO9105867A1
· 1991
[cited by applicant]
WO WO9505465A1
· 1995
[cited by applicant]
WO WO9619573A1
· 1996
[cited by applicant]
WO WO9808934A1
· 1998
[cited by applicant]
WO WO9911781A1
· 1999
[cited by applicant]
WO WO0024893A2
· 2000
[cited by applicant]
WO WO0065070A2
· 2000
[cited by applicant]
WO WO0181405A2
· 2001
[cited by applicant]
WO WO200580545A2
· 2005
[cited by applicant]
WO WO2005121173A1
· 2005
[cited by applicant]
WO WO2007045453A1
· 2007
[cited by applicant]
Dumont, et al, Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives, Crit Rev in Biotechnol, 2016; 36(6): 1110-1122.
[cited by applicant]
EP Patent 3026109 Notice of Opposition (Dec. 7, 2022).
[cited by applicant]
Analysis report of amino acids of BioConcepts “MAM-PF2” medium, dated Dec. 20, 2017.
[cited by applicant]
Appeal decision No. 2016-2179 (
[cited by applicant]
Article 94(3) EPC Communication as issued by the EPO in the divisional application EP15198171.9 of the opposed patent, Feb. 26, 2018.
[cited by applicant]
Ashwell et al., “Carbohydrate-specific receptors of the liver”,
[cited by applicant]
Baetz et al., Developmental changes of free amino acids in bovine fetal fluids with gestational age and the interrelationships between the amino acid concentrations in the fluid compartments,
[cited by applicant]
Barile, Introduction to In Vitro Cytotoxicology Mechanisms and Methods, pp. 1-26, CRC Press, Boca Raton, FL (1994).
[cited by applicant]
Behr-Gross et al., “Collaborative study for the establishment of erythropoietin BRP Batch 2,”
[cited by applicant]
BioConcepts product catalogue: MAM-PF CHO production media, p. 1-8 (2016).
[cited by applicant]
BioConcept, Cell Culture Catalogue (2004).
[cited by applicant]
BioConcept, Cell Culture Catalogue (2015).
[cited by applicant]
Boissel et al., “Erythropoietin structure-function relationships. Mutant protein that test a model of tertiary structure,” J. Biol. Chem., 268(21):15983-15993 (1993).
[cited by applicant]
Burgener et al., “Chapter 3: Medium development in Cell culturre technology for pharmaceutical and cell based therapies,” pp. 41-79 (2006).
[cited by applicant]
Butler, Serum-free media: standardizing cell culture systems,
[cited by applicant]
Chern et al., “Structural role of amino acids 99-110 in recombinant human erythropoietin,” Eur. J. Biochem., 202:225-229 (1991).
[cited by applicant]
Cotes et al., “Bio-assay of erythropoietin in mice made polycythaemic by exposure to air at a reduced pressure”,
[cited by applicant]
Couto et al., “Cloning and expression in
[cited by applicant]
Crowell et al., “Amino acid and manganese supplementation modulates the glycosylation state of erythropoietin in a CHO culture system”,
[cited by applicant]
Crowley et al., “Enzymes and Proteins Containing Manganese: An Overview,” in “Metal Ions in Biological Systems”, vol. 37, “Manganese and its Role in Biological Processess”, Marcel Dekker, Inc. pp. 209-78 (2000).
[cited by applicant]
Darling et al., “Glycosylation of erythropoietin affects receptor binding kinetics: Role of electrostatic interactions”,
[cited by applicant]
Deane et al., “A structural model of the human thrombopoietin receptor complex,” J. Mol. Graph. Model., 15:170-178 (1997).
[cited by applicant]
Declaration of BioConcept, dated Oct. 5, 2017.
[cited by applicant]
Declaration of EPFL concerning the availability of D21, dated Nov. 6, 2017.
[cited by applicant]
Declaration of the German National Library of Medicine (ZB MED) concerning the availability of D45, dated Mar. 28, 2018.
[cited by applicant]
Deeg et al., Soluble TNF receptor fusion protein (TNFR:Fc; Enbrel) in the treatment of patients with myelodysplastic syndrome (MDS),
[cited by applicant]
Delorme et al., “Role of glycosylation on the secretion and biological activity of erythropoietin”,
[cited by applicant]
Dorner et al., “Analysis of Synthesis, Processing and secretion of proteins expressed in mammalian cells”,
[cited by applicant]
Dulbecco et al., “A Plaque Production by the Polyoma Virus,”
[cited by applicant]
Egrie et al., Development and characterization of novel erythropoiesis stimulating protein (NESP),
[cited by applicant]
Egrie et al., “The role of carbohydrate on the biological activity of erythropoietin,”
[cited by applicant]
Elliott et al., “Control of rHuEPO biological activity: The role of carbohydrate”,
[cited by applicant]
Elliott et al., “Enhancement of therapeutic protein in vivo activities through glycoengineering,” Nature Biotechnology. 21:414-421 (2003).
[cited by applicant]
Elliott et al., “Structural requirements for addition of O-linked carbohydrate to recombinant erythropoietin”,
[cited by applicant]
Epoietin Hospira, FDA Advisory Committee Briefing Document, May 25, 2017.
[cited by applicant]
Finley et al., Mn Absorption: The use of CACO-2 cells as a model of the intestinal epithelia,
[cited by applicant]
Goldberg et al., “Oxygen sensing and erythropoietin gene regulation in a human hepatoma cell line”, In:
[cited by applicant]
Goochee et al., “The oligosaccharides of glycoproteins: Bioprocess factors affecting oligosaccharide structure and their effect on glycoprotein properties”,
[cited by applicant]
Ham, Clonal growth of mammalian cells ina chemically defined, synthetic medium,
[cited by applicant]
International Search Report, International Application No. PCT/US2006/046609, mailed Nov. 6, 2007.
[cited by applicant]
Jager, Excerpt of Production of Biologicals from Animal Cells in Culture, pp. 155-166 (1991).
[cited by applicant]
Jensen et al., “The biosynthesis of oligosaccharide-lipids”,
[cited by applicant]
Kaufman et al., “Depletion of manganese within the secretory pathway inhibits O-linked glycosylation in mammalian cells”,
[cited by applicant]
Kelleher et al., “DAD1, the defender against apoptotic cell death, is a subunit of the mammalian oligosaccharyltransferase”,
[cited by applicant]
Kelleher et al., “Oligosacchartyltransferase activity is associated with a protein complex composed of ribophorins I and II and a 48 kd protein”,
[cited by applicant]
Kelleher et al., “Oligosaccharyltransferase isoforms that contain different catalytic STT3 subunits have distinct enzymatic properties”,
[cited by applicant]
Ketley et al., Abstract, “Hemopoietic growth factors”,
[cited by applicant]
Lai et al., “Structural characterization of human erythropoietin,”
[cited by applicant]
Ling et al., “Chemically characterized concentrated corodies for continuous cell culture (the 7Cs culture media),”
[cited by applicant]
MacDougall, “Darbepoetin alfa: A new therapuetic agent for renal anemia,”
[cited by applicant]
Millot et al., “The granulocyte colony-stimulating factor receptor supports erythroid differentiation in the absence of erythropoietin receptor or Stat5”,
[cited by applicant]
Mitra et al., “N-linked oligosaccharies as outfitters for glycoprotein folding, form and function,” Trends in Biochemical Sciences, 13(3):156-163 (2006).
[cited by applicant]
Molineux et al., Excerpt of Erythropoietins and Erythropoiesis, pp. 133-150 (2003).
[cited by applicant]
Nahrgang, PHD Thesis of Stefan Nahrgang (2002).
[cited by applicant]
Non-Final rejection of Feb. 22, 2017 as issued by the USPTO in connection with US 2016/0222075.
[cited by applicant]
Powell et al., “Metal ion activation of galactosyltransferase”,
[cited by applicant]
Press Release: Hospira, STADA and BIOCEUTICALS Enter into Agreements for Erythropoietin,∧ Nov. 20, 2006.
[cited by applicant]
Raju et al., “Glycoengineering of therapeutic glycoproteins: In vitro galactosylation and sialylation of glycoproteins with terminal N-acetylglucosamine and galactose residues”,
[cited by applicant]
Rayner et al., A simple and effective method for the removal of trace metal cations from a mammalian culture medium supplemented with 10% fetal calf serum,
[cited by applicant]
Recny et al., Structural Characterization of Natural Urinary and Recombinant DNA-derived Erythropoietin, Journal of Biological Chemistry 262(35): 17156-17163, Dec. 15, 1987.
[cited by applicant]
Schmitt et al., Grenzwerte forensisch-toxikologischer und chemischer analysenverfahren,
[cited by applicant]
Sharma et al., “Solubilization and characterization of the initial enzymes of the dolichol pathway from yeast”,
[cited by applicant]
Strnad, Jure et al. “Optimization of Cultivation Conditions in Spin Tubes for Chinese Hamster Ovary Cells Producing Erythropoietin and the Comparison of Glycosylation Patterns in Different Cultivation Vessels,” Biotechn…
[cited by applicant]
Sugiura et al., “Purification and characterization of UDP-GalNAc: Polypeptide N-acetylgalactosamine transferase from an ascites hepatoma, AH 66”,
[cited by applicant]
Takeuchi et al., “Comparative study of the asparagine-linked sugar chains of human erythropoietins purified from urine and the culture medium of recombinant Chinese hamster ovary cells”, J.Biol. Chem., J. Biol. Chem., 2…
[cited by applicant]
Takeuchi et al., “Relationship between sugar chain structure and biological activity of recombinant human erythropoietin produced in Chinese hamster ovary cells”,
[cited by applicant]
Test report of BioConcepts “MAM PF2” medium (Translation), dated Sep. 18, 2017.
[cited by applicant]
Witsell et al., “Divalent activation of galactosyltransferase in native mammary golgi vesicles”,
[cited by applicant]
Written Opinion issued by the International Searching Authority (ISA), PCT/US2006/046609, (2008).
[cited by applicant]
Yoon, Sung Kwan et al., “Effect of Low Culture Temperature on Specific Productivity, Transcription Level, and Heterogeneity of Erythropoietin in Chinese Hamster Ovary Cells,” Biotech. and Bioeng. vol. 82, No. 3, pp. 289…
[cited by applicant]
Zanette et al., “Evaluation of phenylboronate agarose for industrial-scale purification of erythropoietin from mammalian cell cultures”, J. Biotech., 101(3): 275-287 (2003).
[cited by applicant]